MOVANTIK is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redhill Biopharma Ltd. The primary component is Naloxegol Oxalate.
Product ID | 57841-1300_046d2fd8-3056-425f-a196-7ff77450368c |
NDC | 57841-1300 |
Product Type | Human Prescription Drug |
Proprietary Name | MOVANTIK |
Generic Name | Naloxegol Oxalate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA204760 |
Labeler Name | RedHill Biopharma Ltd |
Substance Name | NALOXEGOL OXALATE |
Active Ingredient Strength | 13 mg/1 |
Pharm Classes | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0310-1969 | MOVANTIK | naloxegol oxalate |
0310-1970 | MOVANTIK | naloxegol oxalate |
55700-383 | MOVANTIK | naloxegol oxalate |
55700-988 | MOVANTIK | naloxegol oxalate |
57841-1300 | MOVANTIK | naloxegol oxalate |
57841-1301 | MOVANTIK | naloxegol oxalate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MOVANTIK 86205691 4782846 Live/Registered |
AstraZeneca AB 2014-02-27 |
MOVANTIK 86089235 4600146 Live/Registered |
AstraZeneca AB 2013-10-11 |